Edgar Espana is an Ophthalmology physician affiliated with University of South Florida. OpenAlex indexes 173 publications with 5,656 citations (h-index 40).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13330 Usf Laurel Dr
Tampa, FL 336126601
Telephone
813-974-2201Provider last certified this registry record 5 Apr 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
62.6%Prostaglandin Analog27.9%Latanoprost96%Lumigan4%Part D<11 patientsCorticosteroid25.3%Prednisolone Acetate95%Flarex5%Part D<11 patients+ 2 more classes in this area
Anti-infectives
22.6%Fluoroquinolone Antibacterial10.9%Moxifloxacin100%Part D≥69 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor10.5%Valacyclovir100%Part D≥31 patients+ 1 more class in this area
Cardiovascular
8%Beta blocker8%Timolol Maleate100%Part D≥26 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Regulation of tissue repair and scar formation by the stromal niche
University of South Florida
FY2026$431,610R01EY034114 - Regulation of tissue repair and scar formation by the stromal niche
University of South Florida
FY2025$366,869R01EY034114 - Regulation of tissue repair and scar formation by the stromal niche
University of South Florida
FY2024$431,610R01EY034114
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Vogelbaum, MD
University of South Florida
Thomas Casale, MD
University of South Florida
Richard Lockey, MD
University of South Florida
Robert Hauser, MD
University of South Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”